Clinical Trials

Accrual Status
Limit to SWOG Trials

1033 Results

Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8723
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8720

Evaluation of Amonafide in Pancreatic Adenocarcinoma

Activated
07-01-1988
Closed
07-15-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8805
Closed
Phase
Accrual
59%
Published
Closed
Phase
Accrual
83%
Published
SWOG Clinical Trial Number
SWOG-8760
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8755
Closed
Phase
Accrual
71%
Published
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8717
Closed
Phase
Accrual
57%
Published
SWOG Clinical Trial Number
SWOG-8726

Evaluation of Amonafide in Refractory Multiple Myeloma

Activated
04-01-1988
Closed
11-01-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8800
Closed
Phase
Accrual
69%
Published
SWOG Clinical Trial Number
SWOG-8711

A Study of Reproductive Function in Patients with Testicular Cancer

Research Committee(s)
Genitourinary Cancer
Activated
04-01-1988
Closed
06-01-1994
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8804
Closed
Phase
Accrual
30%
Published
SWOG Clinical Trial Number
SWOG-8803
Closed
Phase
SWOG Clinical Trial Number
SWOG-8700
Closed
Phase
Accrual
23%
Published
Closed
Phase
Accrual
77%
Published
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8736 (INT-0093)